IMatinib for PAin in Chronic Treatment of Sickle Cell Anemia (IMPACT SCA): A Pilot Study of Imatinib in Patients with Sickle Cell Anemia and Recurrent Vaso-occlusive Pain

Are you eligible to participate in this study?

You may be eligible for this study if you meet the following criteria:

  • Conditions: Sickle Cell Disease | Sickle Cell Anemia
  • Age: Between 18 - 30 Years
  • Gender: Male or Female
Individuals between 18 and 30 years of age with a documented diagnosis of sickle cell anemia and at least 2 documented episodes of vaso-occlusive pain in the prior year.

Women who are pregnant or breastfeeding will not be eligible.

Recruitment Status


Contact the research team to learn more about this study.

Fields marked with asterisk (*) are required

Please verify that you are not a bot.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.

Volunteer Sign up

Volunteer Registry

Create your profile and be matched to research opportunities

Register Now!

Contact Us

If you need help finding a study or have any questions, please contact us at or by phone at (888) 264-0005.